Evaluation of Changes in Oral Health-related Quality of Life During the Treatment of Periodontitis.
PAROQoL
2 other identifiers
observational
100
1 country
1
Brief Summary
Periodontitis is a chronic inflammatory disease affecting the supporting tissues of the teeth and may negatively affect patients' oral health-related quality of life. Although periodontal treatment is expected to improve periodontal health, its impact on patients' perceived oral quality of life has been less extensively studied. The PAROQoL CROC study is a prospective and monocentric study designed to evaluate changes in oral health-related quality of life in patients with periodontitis undergoing periodontal treatment. Oral quality of life will be assessed using two validated questionnaires, the OHIP-14 and the GOHAI, before treatment and during follow-up. Clinical periodontal parameters, including probing pocket depth, bleeding on probing, plaque levels and clinical attachment loss, will also be collected. The study will investigate the relationship between changes in oral quality of life and clinical periodontal outcomes, as well as the potential influence of patient characteristics and oral hygiene habits. A total of 100 adult patients with periodontitis requiring periodontal treatment will be included.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Oct 2026
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 14, 2026
CompletedStudy Start
First participant enrolled
October 1, 2026
CompletedFirst Posted
Study publicly available on registry
October 9, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
September 1, 2028
October 9, 2026
August 1, 2026
11 months
September 14, 2026
October 6, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Change in OHIP-14 score
Change in OHIP-14 score from before periodontal scaling to the periodontal disease reassessment visit approximately 6-8 weeks later, corresponding to the time required for gingival healing.
Baseline (T0, before treatment); 6-8 weeks after T0 (T1); 6-8 weeks after T1 (T2); 3 months after T2 (T3); 3 months after T3 (T4).
Secondary Outcomes (12)
Change in mean probing pocket depth
From baseline (T0) to the first reassessment visit (T1), approximately 6-8 weeks after initial periodontal treatment.
Change in mean clinical attachment loss
From baseline (T0) to the first reassessment visit (T1), approximately 6-8 weeks after initial periodontal treatment.
Change in mean plaque percentage
From baseline (T0) to the first reassessment visit (T1), approximately 6-8 weeks after initial periodontal treatment.
Change in mean bleeding on probing percentage
From baseline (T0) to the first reassessment visit (T1), approximately 6-8 weeks after initial periodontal treatment.
Change in number of functional units
From baseline (T0) to the first reassessment visit (T1), approximately 6-8 weeks after initial periodontal treatment.
- +7 more secondary outcomes
Eligibility Criteria
The study population will consist of approximately 100 adult patients with periodontitis requiring non-surgical and/or surgical periodontal treatment in the Department of Odontology at Clermont-Ferrand University Hospital. Participants will be French-speaking and able to understand and complete the oral health-related quality of life questionnaires used in the study. Patients will be followed prospectively throughout their periodontal treatment and subsequent reassessment visits.
You may qualify if:
- Patient requiring non-surgical and/or surgical periodontal treatment in the Periodontology Department, Department of Odontology.
- Patient willing to participate in the study and not opposed to participation.
- Patient able to understand and speak French.
You may not qualify if:
- Patient under 18 years of age.
- Patient with cognitive impairment.
- Patient without health insurance coverage.
- Patient under guardianship, curatorship, or judicial safeguard.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
CHU de Clermont-Ferrand
Clermont-Ferrand, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Anne COUDERT
University Hospital, Clermont-Ferrand
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 14, 2026
First Posted
October 9, 2026
Study Start
October 1, 2026
Primary Completion (Estimated)
September 1, 2027
Study Completion (Estimated)
September 1, 2028
Last Updated
October 9, 2026
Record last verified: 2026-08
Data Sharing
- IPD Sharing
- Will not share